Clinical TrailsVertex Shows Promising Phase 1/2 Data for Povetacicept in IgA Nephropathy a... Vertex Shows Promising Phase 1/2 Data for Povetacicept in IgA Nephropathy a... Read Post »
Clinical TrailsGilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacap... Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacap... Read Post »
Clinical TrailsRegeneron Factor XI Antibodies Show Superior Efficacy for VTE Prevention... Regeneron Factor XI Antibodies Show Superior Efficacy for VTE Prevention... Read Post »
Clinical TrailsAmgen’s Repatha® Slashes First Major Cardiovascular Events Risk by 25% i... Amgen’s Repatha® Slashes First Major Cardiovascular Events Risk by 25% i... Read Post »
Clinical TrailsLivdelzi® (Seladelpar) Achieves New Milestone in PBC: Phase 3 Data Show La... Livdelzi® (Seladelpar) Achieves New Milestone in PBC: Phase 3 Data Show La... Read Post »
Clinical TrailsGanaplacide’s Innovative Discovery from 2.3 Million Molecules Yields ... Ganaplacide’s Innovative Discovery from 2.3 Million Molecules Yields ... Read Post »
Clinical TrailsAstraZeneca Baxdrostat Shows Breakthrough 14 mmHg 24-Hour Blood Pressure Re... AstraZeneca Baxdrostat Shows Breakthrough 14 mmHg 24-Hour Blood Pressure Re... Read Post »
Clinical TrailsHope for AFRS Sufferers: Dupixent’s Powerful Phase 3 Outcome Hope for AFRS Sufferers: Dupixent’s Powerful Phase 3 Outcome Read Post »
Clinical TrailsBayer’s Finerenone Significantly Reduces UACR in Adults with Chronic ... Bayer’s Finerenone Significantly Reduces UACR in Adults with Chronic ... Read Post »
Clinical TrailsFirst Oral PCSK9 Inhibitor from Merck Cuts LDL Cholesterol by 59% in HeFH P... First Oral PCSK9 Inhibitor from Merck Cuts LDL Cholesterol by 59% in HeFH P... Read Post »
Clinical TrailsRoche’s Fenebrutinib Achieves Groundbreaking Phase III Success as First O... Roche’s Fenebrutinib Achieves Groundbreaking Phase III Success as First O... Read Post »
Disease & Drugs Drugs Safety Alert ResearchFDA Revises Menopause Hormone Therapy Labels, Removing Black Box Safety War... FDA Revises Menopause Hormone Therapy Labels, Removing Black Box Safety War... Read Post »
Health Tidings ResearchNovo Nordisk and Emcure Join Forces to Expand Semaglutide Market in India w... Novo Nordisk and Emcure Join Forces to Expand Semaglutide Market in India w... Read Post »
Clinical TrailsAtacicept Achieves Breakthrough Phase 3 Results in Immunoglobulin A Nephrop... Atacicept Achieves Breakthrough Phase 3 Results in Immunoglobulin A Nephrop... Read Post »
New Drug ApprovalFDA Approves Linzess (Linaclotide) for Pediatric IBS-C: A Game Changer in T... FDA Approves Linzess (Linaclotide) for Pediatric IBS-C: A Game Changer in T... Read Post »
Clinical TrailsEli Lilly’s Eloralintide Phase 2 Trial shows up to 20% Weight Loss with P... Eli Lilly’s Eloralintide Phase 2 Trial shows up to 20% Weight Loss with P... Read Post »
Drugs Safety Alert ResearchFDA Crackdown: 18 Warning Letters Issued Over Illegal Marketing of Unapprov... FDA Crackdown: 18 Warning Letters Issued Over Illegal Marketing of Unapprov... Read Post »
Clinical TrailsRoche’s Gazyva Shows Breakthrough Phase III Results in Idiopathic Nephrot... Roche’s Gazyva Shows Breakthrough Phase III Results in Idiopathic Nephrot... Read Post »
New Drug ApprovalInnovative Brekiya® DHE Autoinjector Launched by Amneal for Rapid Relief o... Innovative Brekiya® DHE Autoinjector Launched by Amneal for Rapid Relief o... Read Post »
New Drug ApprovalKygevvi Brings Hope for Patients With Rare Mitochondrial Disorder Kygevvi Brings Hope for Patients With Rare Mitochondrial Disorder Read Post »
Clinical TrailsFDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in... FDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in... Read Post »
ResearchSemaglutide Users Report Major Reduction in “Food Noise” and Better Men... Semaglutide Users Report Major Reduction in “Food Noise” and Better Men... Read Post »
Clinical TrailsGefurulimab Symptom Relief in Myasthenia Gravis: PREVAIL Phase 3 Gefurulimab Symptom Relief in Myasthenia Gravis: PREVAIL Phase 3 Read Post »
Drugs Safety Alert ResearchFDA’s New Move to Protect Children from Unapproved Fluoride Drug Prod... FDA’s New Move to Protect Children from Unapproved Fluoride Drug Prod... Read Post »
Health Tidings ResearchPfizer vs. Novo Nordisk: The High-Stakes Battle for Metsera Pfizer vs. Novo Nordisk: The High-Stakes Battle for Metsera Read Post »
Drugs Safety Alert ResearchTeva Pharmaceuticals Issues Voluntary Recall of Prazosin Hydrochloride Caps... Teva Pharmaceuticals Issues Voluntary Recall of Prazosin Hydrochloride Caps... Read Post »
Clinical TrailsNovartis Presents Positive Phase III NEPTUNUS-1 and NEPTUNUS-2 Trial Result... Novartis Presents Positive Phase III NEPTUNUS-1 and NEPTUNUS-2 Trial Result... Read Post »
Clinical TrailsBridgeBio Announces Positive Phase 3 CALIBRATE Trial Results for Encaleret ... BridgeBio Announces Positive Phase 3 CALIBRATE Trial Results for Encaleret ... Read Post »
Drugs Safety Alert ResearchFDA Safety Alert: Increased Reports of Severe Allergic Reactions to Specifi... FDA Safety Alert: Increased Reports of Severe Allergic Reactions to Specifi... Read Post »
Disease & Drugs New Drug ApprovalNew FDA Indication for WINREVAIR: Reducing Hospitalizations and Mortality i... New FDA Indication for WINREVAIR: Reducing Hospitalizations and Mortality i... Read Post »
Clinical TrailsIntellia Pauses Phase 3 CRISPR Trials after Life-Threatening Liver Injury i... Intellia Pauses Phase 3 CRISPR Trials after Life-Threatening Liver Injury i... Read Post »
Drugs Safety Alert ResearchFDA Tightens Warnings on Tranexamic Acid Amid Deadly Mix-Ups with Spinal An... FDA Tightens Warnings on Tranexamic Acid Amid Deadly Mix-Ups with Spinal An... Read Post »
Clinical TrailsSanofi’s Efdoralprin Alfa Achieves All Primary Endpoints in Phase 2 ElevA... Sanofi’s Efdoralprin Alfa Achieves All Primary Endpoints in Phase 2 ElevA... Read Post »
Clinical TrailsInnovent and Lilly’s Mazdutide Outperforms Semaglutide in Phase 3 DREAMS-... Innovent and Lilly’s Mazdutide Outperforms Semaglutide in Phase 3 DREAMS-... Read Post »
New Drug ApprovalBayer’s Lynkuet: FDA Approves Non-Hormonal Pill for Hot Flashes in Menopa... Bayer’s Lynkuet: FDA Approves Non-Hormonal Pill for Hot Flashes in Menopa... Read Post »
New Drug ApprovalLupin Launches Authorized Generic and Endo Launches First Generic Versions ... Lupin Launches Authorized Generic and Endo Launches First Generic Versions ... Read Post »
New Drug ApprovalFDA Re-approves GSK’s Blenrep (Belantamab Mafodotin-blmf) Combo for Relap... FDA Re-approves GSK’s Blenrep (Belantamab Mafodotin-blmf) Combo for Relap... Read Post »
Clinical TrailsLong-Term SELECT Trial: Semaglutide Cuts Cardiovascular Events by 20% beyon... Long-Term SELECT Trial: Semaglutide Cuts Cardiovascular Events by 20% beyon... Read Post »
Clinical TrailsNipocalimab Delivers Breakthrough Efficacy and Safety in Sjögren’s Disea... Nipocalimab Delivers Breakthrough Efficacy and Safety in Sjögren’s Disea... Read Post »
New Drug ApprovalFDA Expands Approval of Revumenib for NPM1-Mutated Relapsed or Refractory A... FDA Expands Approval of Revumenib for NPM1-Mutated Relapsed or Refractory A... Read Post »
Clinical TrailsAlector Faces Major Setback as Latozinemab Fails Phase 3 Trial, Cuts 50% St... Alector Faces Major Setback as Latozinemab Fails Phase 3 Trial, Cuts 50% St... Read Post »
Clinical TrailsModerna’s mRNA‑1647 CMV Vaccine Fails in Late‑Stage Trial, Showing On... Moderna’s mRNA‑1647 CMV Vaccine Fails in Late‑Stage Trial, Showing On... Read Post »
Health Tidings New Drug ApprovalMounjaro Now Cipla’s Yurpeak: A New Chapter for Tirzepatide in India Mounjaro Now Cipla’s Yurpeak: A New Chapter for Tirzepatide in India Read Post »
Clinical Trails ResearchFirst Successful Restoration of Central Vision in Dry AMD Using Subretinal ... First Successful Restoration of Central Vision in Dry AMD Using Subretinal ... Read Post »
New Drug ApprovalGlaukos’ Epioxa™ Wins FDA Nod: A Game-Changer for Keratoconus Patients Glaukos’ Epioxa™ Wins FDA Nod: A Game-Changer for Keratoconus Patients Read Post »
New Drug ApprovalFDA Approves Gazyva for Lupus Nephritis, Extending Roche and Biogen’s CD2... FDA Approves Gazyva for Lupus Nephritis, Extending Roche and Biogen’s CD2... Read Post »
ResearchWhat the WHO 2025 Antibiotic Resistance Report Warns: The World’s Fight a... What the WHO 2025 Antibiotic Resistance Report Warns: The World’s Fight a... Read Post »
ResearchFSSAI Bans Misleading Use of ORS Label on Fruit Juices: Dr. Sivaranjani San... FSSAI Bans Misleading Use of ORS Label on Fruit Juices: Dr. Sivaranjani San... Read Post »
Clinical TrailsNovo Nordisk’s Monlunabant Shows Promising Weight Loss and Metabolic Bene... Novo Nordisk’s Monlunabant Shows Promising Weight Loss and Metabolic Bene... Read Post »
Clinical TrailsHigher-Dose Semaglutide Achieves Historic 21% Weight Loss in Landmark STEP ... Higher-Dose Semaglutide Achieves Historic 21% Weight Loss in Landmark STEP ... Read Post »
